NCT00436059View on ClinicalTrials.gov

The Efficacy of Velcade on Bone Tissue During Myelomatosis (Bone Marrow Cancer)

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions
Multiple Myeloma
Interventions
DRUG

bortezomib

Trial Locations (2)

5000

University Hospital Odense, Odense

7100

Vejle Hospital, Vejle

All Listed Sponsors
collaborator

Odense University Hospital

OTHER

lead

Vejle Hospital

OTHER

NCT00436059 - The Efficacy of Velcade on Bone Tissue During Myelomatosis (Bone Marrow Cancer) | Biotech Hunter | Biotech Hunter